National HealthCare (NHC) Stock Price, News & Analysis

Company Overview

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States. Its facilities and service partnerships span markets in Tennessee, Alabama, Florida, Texas and neighboring states. The company tailors clinical programs to residents’ needs, with services ranging from short-term therapy following hospitalization to ongoing care for individuals with chronic conditions.

Founded in 1970, NHC has grown both organically and through strategic acquisitions of individual care communities and therapy providers. Its longstanding focus on integrated care models seeks to improve clinical outcomes while managing the overall cost of care. The company’s leadership team brings experience in healthcare operations, finance and clinical disciplines to support its mission of delivering quality care and enhancing the resident experience.

Key Stats

• Today's Range: $216.27 to $220.86
• 50-Day Range: $167.05 to $218.44
• 52-Week Range: $93.54 to $220.86
• Volume: 103,124 shs
• Average Volume: 111,907 shs
• Market Capitalization: $3.40 billion
• P/E Ratio: 27.63
• Dividend Yield: 1.23%
• Price Target: N/A
• Consensus Rating: Buy

National HealthCare Stock Analysis - MarketRank™

National HealthCare scored higher than 74% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Buy

Consensus Rating

National HealthCare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, no buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

National HealthCare has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of National HealthCare is 27.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 46.24.

Price to Earnings Ratio vs. Sector

The P/E ratio of National HealthCare is 27.63, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.35.

Price to Book Value per Share Ratio

National HealthCare has a P/B Ratio of 3.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.11% of the float of National HealthCare has been sold short.

Short Interest Ratio / Days to Cover

National HealthCare has a short interest ratio ("days to cover") of 4.49.

Change versus previous month

Short interest in National HealthCare has recently decreased by 7.01%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

National HealthCare pays a meaningful dividend of 1.23%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

National HealthCare has been increasing its dividend for 10 years.

Dividend Coverage

The dividend payout ratio of National HealthCare is 61.89%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.55

News Sentiment

National HealthCare has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for National HealthCare this week, compared to 2 articles on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $174,863.00 in company stock, which represents 0.0051% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, National HealthCare insiders have bought more of their company's stock than they have sold. Specifically, they have bought $174,863.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

13.92% of the stock of National HealthCare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

56.44% of the stock of National HealthCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 4/30 Dividend: 3/31/2026
• Ex-Dividend for 4/30 Dividend: 3/31/2026
• Dividend Payable: 4/30/2026
• Last Earnings: 5/07/2026
• Record date for 7/31 Dividend: 6/30/2026
• Ex-Dividend for 7/31 Dividend: 6/30/2026
• Today: 7/06/2026
• Dividend Payable: 7/31/2026
• Next Earnings (Estimated): 8/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Medical
• Industry: MED - NURSING HMS
• Sub-Industry: Health Care Facilities
• Current Symbol: NYSEAMERICAN:NHC
• Previous Symbol: NYSEMKT:NHC
• CIK: 1047335
• Web: www.nhccare.com
• Phone: (615) 890-2020
• Fax: 615-890-0123
• Employees: 15,278
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $4.33
• Trailing P/E Ratio: 27.63
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $120.01 million
• Net Margins: 8.10%
• Pretax Margin: 10.72%
• Return on Equity: 9.98%
• Return on Assets: 6.87%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.86
• Quick Ratio: 1.82

Sales & Book Value

• Annual Sales: $1.52 billion
• Price / Sales: 2.24
• Cash Flow: $9.28 per share
• Price / Cash Flow: 23.44
• Book Value: $69.25 per share
• Price / Book: 3.14

Miscellaneous

• Outstanding Shares: 15,620,000
• Free Float: 13,446,000
• Market Cap: $3.40 billion
• Optionable: Not Optionable
• Beta: 0.63